🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Wie met griep of COVID-19 op intensieve zorgen terechtkomt loopt risico op levensbedreigende schimmelinfecties. Diagnostische alertheid is essentieel! vrt.be/vrtnws/nl/2021…

1 augustus is Werelddag voor Longkanker. Stichting tegen Kanker vestigt de aandacht op de meest voorkomende en dodelijkste kanker wereldwijd en ijvert voor meer preventie, screening en betere behandeling via financiële steun aan onderzoekers. 👉 bit.ly/3C7rATo

Impressive data from the DESTINY-Lung01 trial for pts with #HER2 mutant #NSCLC, most of them with multiple lines of tx, showing: ⚪ ORR 52%, DCR 92% ⚪ mPFS 8.2m ⚪ mOS 17.8 m 🚨 But 26% of any grade #pneumonitis and 2 toxic deaths❗ #ESMO21 OncoAlert #lcsm NEJM

#COVID19 | Vaccinatie geeft een doeltreffende bescherming tegen ernstige ziekte 💉 Meer info 👇 sciensano.be/nl/pershoek/im…

Beste mensen die nog steeds twijfelen zich al dan niet te laten vaccineren. Laat dit virus aub niet toe u in diepe miserie te brengen. vrt.be/vrtnws/nl/2021…

New #JITC article: Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitis bit.ly/3UNDw5M Amelie Franken @PierreVM0 Els Wauters

Happy to share our single cell transcriptomics data on ICI-related pneumonitis in #JITC

So grateful and proud to see my PhD student Elin Pauwels receive the Marie Curie award at #EANM22. Best scientific abstract out of >1500 accepted ones. Thx to entire study team. Great motivation to get Al18F-Oc reimbursed for SSTR PET. @officialEANM, UZ Leuven, @komop_tgkanker

Come see our poster on #ICI-pneumonitis at #ELCC23 > Cross talk pathogenic Th17.1 cells ↔️ inflammatory monocytes > IFNy-driven inflammatory signature 🔥confirmed > CXCL10/CXCL8 in BALF as potential diagnostic tool Collaboration with Johns Hopkins Kimmel Cancer Center Jarushka Naidoo and @suresh_lab

🔉 Recurrent? Resistant? Refractory? Let's speak the same #language! 📄 Interesting and necessary Society for Immunotherapy of Cancer consensus definitions for #irAE terminology. Read it here 👇 💪 Jarushka Naidoo Dr. Julie Brahmer Elad Sharon @cappelliMD

B.J. Kennedy Geriatric Oncology Award for Prof. Hans Wildiers MD, PhD today at the ASCO Annual Meeting 2023 for his outstanding contributions to the important field of cancer in the elderly. Congratulations from our whole team!

BAM! He did it 🙌 Smooth defense, proudest promoter! Thank you @PierreVM0 for this enriching adventure. Also thanks to @DiLa_lab Elena Donders and the jury Andreas Pircher Sandrine Aspeslagh Jarushka Naidoo Cell Stress & Immunity (CSI) Lab Thierry Voet

Come see what our PhD student is up to ESMO - Eur. Oncology in Hall 8 #forx

We did it 🎉 Our team VZN-KUL REspiratory Oncology team reached the finish line! Happy and proud to continue our contribution to highly needed cancer research 💪 #VZNKULREO #100kmRun #KomOpTegenKanker #teamwork #ThankYou #TogetherStrong

Come and check our poster 113P at #ELCC2024 on AI entering our MTB discussions to decide on local treatment modality for early-stage lung cancer #leuvenlungcancergroup Nicole Filipow Maarten Lambrecht herbert decaluwe Christophe Deroose

Radiomics to predict ILD in pacific study. Reticulation volume and total lung volume two promising features. Very elegant presentation from Jarushka Naidoo #ESMO24 . Very high negative predictive value, perhaps room for improvement for positive predictive value (false positive rate).

Our poster 140P is up at #ESMO2024 Elena Donders @PierreVM0 @DiLa_lab Sampling site matters 🫁 Immunological changes in tumor-draining lymph nodes upon invasion are predictive of durable ICB response in NSCLC. Key rol for DCs 🔑

A superb poster by Marthe Verhaert at #ESMO24 to present the results of the amazing work they are doing with the BITOX, the Belgian ImmunoTOXicity board of Belgian Society of Medical Oncology, thanks for being there to guide us in the treatment of rare and tricky toxicities 🤔🤓

AIBED: Evaluation of biomarker testing and treatment paterns in Belgian lung cancer patients by means of AI and Natural Language Processing. Challenges of this method for data extraction and analysis still remain!

Clinical spectrum & outcome of KRAS-Mt aNSCLC. In RWD no influence of KRAS subtype (G12C vs non-G12C) on OS. At PD, mPFS 5.2 mo for docetaxel-treated and 7.6mo for oral KRASi-treated in KRAS G12C pts #elcc2025 #leuvenlungcancergroup